Sensiva Health Unveils Siemens Atellica System to Enhance Same-Day Blood Testing for Customers Nationwide

Ben Williamson to lead Sensiva Health as Dr. Jim Silliman is stepping down as CEO and will transition to The Board of Directors, effective immediately.

With U.S. labs taking days and weeks to deliver COVID-19 test results to health agencies, clinicians, and patients, government authorities in hard-hit states like Florida and Louisiana have said enough, canceling contracts with major reference labs.

It’s one thing to have false positive, but false negative – that’s when you’re failing the patient. At the height of the breakout, I didn’t believe any result. I looked at the patients and told them, this result is negative but I’m still going to treat you because you have all the symptoms.

Sensiva can provide Caribbean healthcare providers with risk exposure information and guidance immediately after results are received via an online report, or by phone through Sensiva’s proprietary mobile application. While both clearly explain the test results, a team of telemedicine professionals will also be available to answer questions via live chat, email, or phone support.

Cormeum Lab Services LLC, a high-volume Clinical Laboratory Improvement Amendments (CLIA) certified medical lab based in Marrero, Louisiana, recently received approval of its Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a PCR-based SARS-CoV-2 test. In addition, based on the approximately 175 clinical samples submitted to the FDA as part of its EUA approval process, Cormeum's testing solution received a 100% accuracy rating for both specificity and sensitivity.

Sensiva has sought expedited examination of its patent application, and through its affiliate Cormeum Lab Services, LLC, has filed for Emergency Use Authorization through the U.S. Food and Drug Administration.

As a company solely focused on COVID-19 testing, and that is aggressively adding throughput, Sensiva currently has the ability to manufacture, deliver and process over 100,000 tests per week and anticipates having the ability to increase up to 500,000 tests per week within approximately the next 45 days.